The European Union implemented new legislation in June 2026 regarding plants developed using novel genomic techniques. The regulation introduces a two-category system: Category 1 (NGT-1) plants, which have minimal genetic changes similar to natural or conventional breeding methods, will be treated similarly to traditionally bred plants. Category 2 plants, with more complex modifications, will continue to fall under strict GMO regulations. Dr. Jürgen Kleine-Vehn discusses how genome editing allows precise, targeted changes to plant genomes without leaving residual genetic material, making NGT-1 plants scientifically equivalent to conventionally bred plants. He emphasizes that safety concerns related to genome-edited plants are unfounded, as their molecular changes mirror those from natural processes. However, broader issues around agricultural control and corporate influence remain relevant.
Bias read (Center): The article presents a balanced explanation of the EU's regulatory framework for gene-editing technology, focusing on scientific distinctions between NGT-1 and NGT-2 plants. It includes perspectives from a plant scientist without overt ideological framing, emphasizing technical and regulatory facts.






